168 related articles for article (PubMed ID: 23586499)
1. Editorial comment to salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
Fukumori T
Int J Urol; 2013 Dec; 20(12):1183. PubMed ID: 23586499
[No Abstract] [Full Text] [Related]
2. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
Ishiyama H; Teh BS; Blanco AI; Paulino AC; Mai WY; Caillouet J; Xu B; Butler EB
Int J Urol; 2013 Dec; 20(12):1178-83. PubMed ID: 23573867
[TBL] [Abstract][Full Text] [Related]
3. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
[TBL] [Abstract][Full Text] [Related]
4. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.
Ost P; De Troyer B; Fonteyne V; Oosterlinck W; De Meerleer G
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1316-22. PubMed ID: 20675081
[TBL] [Abstract][Full Text] [Related]
5. Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT.
Canter D; Greenberg RE; Horwitz EM; Kutikov A; Li J; Long C; Buyyounouski M; Boorjian SA
Can J Urol; 2010 Oct; 17(5):5365-9. PubMed ID: 20974028
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
Wahart A; Guy JB; Vallard A; Geissler B; Ben Mrad M; Falk AT; Prevot N; de Laroche G; Rancoule C; Chargari C; Magné N
Br J Radiol; 2016; 89(1058):20150579. PubMed ID: 26648528
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Versus Salvage Radiotherapy Following Radical Prostatectomy: Meta-analysis of the Effect of Comparator Salvage Approach on Study Conclusions.
Wallis CJD; Klaassen Z; Luckenbaugh AN; Laviana AA; Bhindi B
Eur Urol; 2020 Mar; 77(3):395-396. PubMed ID: 31735431
[No Abstract] [Full Text] [Related]
8. Editorial comment on: Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Graefen M
Eur Urol; 2009 Feb; 55(2):410-1. PubMed ID: 18639971
[No Abstract] [Full Text] [Related]
9. Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer.
Bottke D; de Reijke TM; Bartkowiak D; Wiegel T
Eur J Cancer; 2009 Sep; 45 Suppl 1():148-57. PubMed ID: 19775613
[No Abstract] [Full Text] [Related]
10. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
[TBL] [Abstract][Full Text] [Related]
11. Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.
Fersino S; Tebano U; Mazzola R; Giaj-Levra N; Ricchetti F; Di Paola G; Fiorentino A; Sicignano G; Naccarato S; Ruggieri R; Cavalleri S; Alongi F
Clin Genitourin Cancer; 2017 Aug; 15(4):e667-e673. PubMed ID: 28237181
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy in high-grade prostate cancer, salvage and adjuvant radiotherapy.
Brodak M; Kosina J; Holub L; Louda M; Odrazka K; Dolezel M; Sefrová J; Jansa J; Pacovsky J
Urol Int; 2011; 86(2):146-51. PubMed ID: 20975252
[TBL] [Abstract][Full Text] [Related]
13. Should androgen suppression be used in salvage radiotherapy of biochemical recurrence after prostatectomy?
Benderli Cihan Y
J BUON; 2018; 23(1):277-278. PubMed ID: 29552802
[No Abstract] [Full Text] [Related]
14. Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy.
Smeenk RJ; van Lin EN; van Kollenburg P; McColl GM; Kunze-Busch M; Kaanders JH
Radiother Oncol; 2011 Dec; 101(3):465-70. PubMed ID: 21872953
[TBL] [Abstract][Full Text] [Related]
15. Editorial Comment to Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
Simon RM; Freedland SJ; Vidal AC
Int J Urol; 2015 Jan; 22(1):88. PubMed ID: 25208854
[No Abstract] [Full Text] [Related]
16. Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients.
Byun SJ; Kim YS; Ahn H; Kim CS
PLoS One; 2018; 13(1):e0190479. PubMed ID: 29320570
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
Ward JF
Eur Urol; 2010 Mar; 57(3):444-5. PubMed ID: 19303198
[No Abstract] [Full Text] [Related]
18. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
Patel A
Eur Urol; 2010 Mar; 57(3):444. PubMed ID: 19303196
[No Abstract] [Full Text] [Related]
19. Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?
Bossi A; De Meerleer G; Ost P
Eur Urol; 2011 Dec; 60(6):1149-50; discussion 1150-1. PubMed ID: 21920662
[No Abstract] [Full Text] [Related]
20. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.
De Meerleer G; Fonteyne V; Meersschout S; Van den Broecke C; Villeirs G; Lumen N; Ost P; Vandecasteele K; De Neve W
Radiother Oncol; 2008 Nov; 89(2):205-13. PubMed ID: 18771809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
